Streetbeat News

Stock Prices

AUPH

Aurinia Pharmaceuticals shares rose following the announcement of a board restructuring to consist of seven members.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:17 pm

LKCO

Luokung Technology Corp. plans to implement an 8-to-1 share combination, which is a reverse stock split. This move is likely aimed at increasing the stock price to meet listing requirements or improve market perception.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:16 pm

ORCL

Oracle shares are experiencing an uptick following the company's announcement of a projected revenue of at least $104 billion for its fiscal year 2029.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:14 pm

NBIX

Neurocrine Biosciences announced that their Phase 2 study for Luvadaxistat did not meet its primary endpoint for treating cognitive impairment in schizophrenia. The company will now focus on Phase 3 development of other drugs for schizophrenia and major depressive disorder.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:11 pm

GLBS

Globus Maritime (NASDAQ:GLBS) reported Q2 earnings of $0.16 per share, significantly beating the $0.04 estimate, and sales of $9.52M, surpassing the $7.80M estimate. This marks a substantial improvement from the previous year's losses and sales figures.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:10 pm

ORCL

Oracle projects its revenue to reach at least $104 billion by fiscal year 2029, indicating strong growth expectations.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:10 pm

IMRX

Immuneering shares rise following positive initial response data from a Phase 2a clinical trial involving IMM-1-104 for pancreatic cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:10 pm

IMRX

Immuneering has announced initial Phase 2a data for its treatment IMM-1-104 combined with modified Gemcitabine/Nab-Paclitaxel. The results from the first five patients show a 40% overall response rate (ORR) and an 80% disease control rate.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:09 pm

BA

FOUR

SPCE

Jared Isaacman, CEO of Shift4 Payments, participated in a private spacewalk as part of the SpaceX Polaris Dawn mission. This raises concerns about potential risks to Shift4 Payments shareholders due to the dangers associated with space travel.

Portfolio Pulse from Chris Katje

September 12, 2024 | 8:09 pm

RH

RH shares rose following the release of Q2 financial results that exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:08 pm